Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Pilot Study Evaluating Synera® in the Treatment of Patients With Shoulder Impingement Syndrome

NCT01055444 is registered in ClinicalTrials.gov with ZARS Pharma Inc. as lead sponsor.

NCT NCT01055444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01055444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Pilot Study Evaluating Synera® in the Treatment of Patients With Shoulder Impingement Syndrome
Lead sponsor
ZARS Pharma Inc.
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2010
Completion date
September 30, 2010
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

shoulder impingement syndrome